A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers

Suman Rao1, Guangyan Du2, Marc Hafner3

  • 1Laboratory of Systems Pharmacology, Boston, Massachusetts 02115; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115.

Insights

This study introduces a novel non-genetic method to discover cancer vulnerabilities by using a multitargeted kinase inhibitor. Dual inhibition of MEK1/2 and IGF1R/INSR effectively blocks cancer cell proliferation, highlighting a new strategy for polypharmacology in cancer treatment.

Area of Science:

  • Cancer Biology
  • Pharmacology
  • Molecular Signaling

Background:

  • Cancer cells rely on complex signaling networks for survival, often developing resistance to single-target drugs.
  • Polypharmacology, using drugs that target multiple proteins, offers clinical advantages but is difficult to discover and validate.
  • Identifying exploitable signaling vulnerabilities in cancer requires innovative strategies beyond traditional genetic approaches.

Purpose of the Study:

  • To develop a non-genetic strategy for identifying cancer cell proliferation drivers and exploitable signaling vulnerabilities.
  • To utilize a multitargeted kinase inhibitor (SM1-71) as a tool to discover effective polypharmacology combinations.
  • To validate the approach in a KRAS-dependent non-small cell lung cancer (NSCLC) cell line.

Main Methods:

  • Employed a multitargeted kinase inhibitor, SM1-71, as a tool compound.
  • Utilized phenotypic screens and signaling analyses to identify target combinations.
  • Applied kinase inhibitors to test the efficacy of dual inhibition strategies.

Main Results:

  • Identified dual inhibition of MEK1/2 and insulin-like growth factor 1 receptor (IGF1R)/insulin receptor (INSR) as critical for blocking proliferation in H23-KRASG12C NSCLC cells.
  • Demonstrated the effectiveness of the non-genetic strategy in discovering a specific polypharmacology combination.
  • Validated the utility of SM1-71 as a tool compound for uncovering kinase dependencies.

Conclusions:

  • Multitargeted tool compounds with well-defined polypharmacology are valuable for discovering kinase dependencies in cancer.
  • The described non-genetic strategy is complementary to genetic approaches and generalizable to other cancer systems.
  • This approach enables future mechanistic and translational studies of polypharmacology in cancer signaling vulnerabilities.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
130.3K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.0K
Paracrine Signaling01:21

Paracrine Signaling

Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
59.6K
Bacterial Signaling01:30

Bacterial Signaling

Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
40.6K
Synaptic Signaling01:12

Synaptic Signaling

Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
79.3K